P+F Products + Features GmbH announced that it received FDA breakthrough device designation for its TricValve system. Vienna-based P+F received the breakthrough nod earlier this month for the transcatheter bicval valves system, comprised of two self-expanding biological valves for the treatment of patients with hemodynamically relevant tricuspid insufficiency and caval reflux, according to a news […]